Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 38
Filter
1.
Oncogene ; 34(35): 4647-55, 2015 Aug 27.
Article in English | MEDLINE | ID: mdl-25486434

ABSTRACT

Somatic mutations in the gene encoding the catalytic subunit of protein phosphatase 6 (Ppp6c) have been identified in malignant melanoma and are thought to function as a driver in B-raf- or N-ras-driven tumorigenesis. To assess the role of Ppp6c in carcinogenesis, we generated skin keratinocyte-specific Ppp6c conditional knockout mice and performed two-stage skin carcinogenesis analysis. Ppp6c deficiency induced papilloma formation with 7,12-dimethylbenz (a) anthracene (DMBA) only, and development of those papillomas was significantly accelerated compared with that seen following DMBA/TPA (12-O-tetradecanoylphorbol 13-acetate) treatment of wild-type mice. NF-κB activation either by tumor necrosis factor (TNF)-α or interleukin (IL)-1ß was enhanced in Ppp6c-deficient keratinocytes. Overall, we conclude that Ppp6c deficiency predisposes mice to skin carcinogenesis initiated by DMBA. This is the first report showing that such deficiency promotes tumor formation in mice.


Subject(s)
Phosphoprotein Phosphatases/genetics , Skin Neoplasms/enzymology , 9,10-Dimethyl-1,2-benzanthracene , Animals , Carcinogenesis/metabolism , Cells, Cultured , Keratinocytes/enzymology , Mice, Inbred C57BL , Mice, Inbred CBA , Mice, Transgenic , NF-kappa B/metabolism , Phosphoprotein Phosphatases/metabolism , Signal Transduction , Skin/enzymology , Skin/pathology , Skin Neoplasms/chemically induced
3.
Oncogene ; 28(5): 752-61, 2009 Feb 05.
Article in English | MEDLINE | ID: mdl-19043453

ABSTRACT

Recent studies have demonstrated essential functions for KIF3, a microtubule-directed protein motor, in subcellular transport of several cancer-related proteins, including the beta-catenin-cadherin(s) complex. In this study, we report identification of the protein-phosphatase Dusp26 as a novel regulator of the KIF3 motor. Here we undertake yeast two-hybrid screening and identify Kif3a, a motor subunit of the KIF3 heterotrimeric complex, as a novel Dusp26-binding protein. Co-immunoprecipitation and colocalization experiments revealed that Dusp26 associates not only with Kif3a, but also with Kap3, another subunit of the KIF3 complex. Dephosphorylation experiments in vitro and analysis using mutant forms of Dusp26 in intact cells strongly suggested that Dusp26 is recruited to the KIF3 motor mainly by interaction with Kif3a, and thereby dephosphorylates Kap3. Forced expression of Dusp26, but not its catalytically inactive mutant, promoted distribution of beta-catenin/N-cadherin, an established KIF3 cargo, to cell-cell junction sites, resulting in increased cell-cell adhesiveness. We also showed that Dusp26 mRNA expression was downregulated in human glioblastoma samples. These results suggest previously unidentified functions of Dusp26 in intracellular transport and cell-cell adhesion. Downregulation of Dusp26 may contribute to malignant phenotypes of glioma.


Subject(s)
Cadherins/physiology , Cell Communication/physiology , Dual-Specificity Phosphatases/metabolism , Kinesins/metabolism , Mitogen-Activated Protein Kinase Phosphatases/metabolism , Adaptor Proteins, Signal Transducing/metabolism , Animals , Brain Neoplasms/enzymology , Brain Neoplasms/genetics , COS Cells , Cadherins/metabolism , Cell Adhesion , Chlorocebus aethiops , Cytoskeletal Proteins/metabolism , Dual-Specificity Phosphatases/genetics , Gene Expression Regulation, Enzymologic , Gene Expression Regulation, Neoplastic , Glioma/enzymology , Glioma/genetics , HeLa Cells , Humans , Mice , Mitogen-Activated Protein Kinase Phosphatases/genetics , Molecular Motor Proteins/metabolism , NIH 3T3 Cells , Phosphorylation , Protein Binding
4.
Blood ; 98(10): 3030-4, 2001 Nov 15.
Article in English | MEDLINE | ID: mdl-11698287

ABSTRACT

Protein tyrosine phosphatase (PTP) epsilon (PTPepsilon) exists as 2 forms generated by alternative promoter usage. It has recently been reported that a cytosolic isoform of PTPepsilon (PTPepsilonC) when over-expressed in murine M1 myeloid cells inhibits interleukin-6 (IL-6)- and leukemia inhibitory factor-induced activation of Janus kinases (JAKs), thereby suppressing STAT3 tyrosine phosphorylation and STAT3 signaling. This study characterizes an inhibitory action of PTPepsilonC on IL-6 signaling and also reveals that PTPepsilonC inhibitory activity is independent of other potential negative regulators, such as SHP-2 and SOCS family proteins. Furthermore, it analyzes the selectivity of PTPepsilonC action toward several cytokines. On IL-6 stimulation, expression of PTPepsilonC-DA, a catalytically inactive mutant of PTPepsilonC, results in an earlier onset of STAT3 tyrosine phosphorylation, suggesting different modes of action between PTPepsilonC and other negative regulators. In addition, the study shows PTPepsilonC-DA enhances activation of STAT1 by IL-6 as well. In terms of specificity to cytokines, over-expressed PTPepsilonC also inhibits IL-10-induced tyrosine phosphorylation of STAT3 in M1 cells, whereas PTPepsilonC does not affect either interferon-beta- and interferon-gamma-induced tyrosine phosphorylation of STATs or expression of STAT transcriptional targets. Among cytokines tested, the inhibitory effect of PTPepsilonC is selective to IL-6- and IL-10-induced JAK-STAT signaling.


Subject(s)
DNA-Binding Proteins/physiology , Interleukin-10/antagonists & inhibitors , Interleukin-6/antagonists & inhibitors , Intracellular Signaling Peptides and Proteins , Isoenzymes/physiology , Protein Tyrosine Phosphatases/physiology , Protein-Tyrosine Kinases/physiology , Repressor Proteins , Signal Transduction/drug effects , Trans-Activators/physiology , Transcription Factors , 3T3 Cells , Animals , Carrier Proteins/physiology , Cells, Cultured , Humans , Interferon-beta/pharmacology , Interferon-gamma/pharmacology , Isoenzymes/genetics , Janus Kinase 1 , Mice , Myeloid Cells/cytology , Myeloid Cells/drug effects , Myeloid Cells/enzymology , Phosphorylation , Protein Processing, Post-Translational , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , Protein Tyrosine Phosphatase, Non-Receptor Type 6 , Protein Tyrosine Phosphatases/genetics , Proteins/physiology , Receptor-Like Protein Tyrosine Phosphatases, Class 4 , Receptors, Interleukin/drug effects , Receptors, Interleukin-10 , Recombinant Fusion Proteins/physiology , STAT1 Transcription Factor , STAT3 Transcription Factor , Suppressor of Cytokine Signaling 1 Protein , Suppressor of Cytokine Signaling 3 Protein , Suppressor of Cytokine Signaling Proteins , TYK2 Kinase , Transfection
5.
Neuroreport ; 12(7): 1465-8, 2001 May 25.
Article in English | MEDLINE | ID: mdl-11388431

ABSTRACT

The role of endothelin-1 (ET-1) in the development of experimental autoimmune encephalomyelitis (EAE) was studied by the blocking the action of ET-1 with a receptor antagonist, BQ-123. Intrathecal administration of BQ-123 significantly ameliorated EAE progression at the peak stage of EAE (p<0.05). By immunohistochemistry, ED-1-positive macrophages in EAE lesions were identified as major producers of ET-1, whereas the immunoreactivity of ET-1 on brain cells, such as astrocytes, was dramatically increased in accordance with the progression of EAE. This study points to a putative pro-1nflammatory role for ET-1 in the pathogenesis of EAE. One possible application for the ET-1 receptor antagonist might be helpful in the therapy of autoimmune neurological disorders.


Subject(s)
Antihypertensive Agents/pharmacology , Demyelinating Diseases/physiopathology , Encephalomyelitis, Autoimmune, Experimental/physiopathology , Endothelin Receptor Antagonists , Endothelin-1/antagonists & inhibitors , Peptides, Cyclic/pharmacology , Spinal Cord/drug effects , Animals , Astrocytes/drug effects , Astrocytes/metabolism , Astrocytes/pathology , Blood Vessels/drug effects , Blood Vessels/pathology , Blood Vessels/physiopathology , Demyelinating Diseases/drug therapy , Demyelinating Diseases/pathology , Disease Models, Animal , Encephalitis/drug therapy , Encephalitis/pathology , Encephalitis/physiopathology , Encephalomyelitis, Autoimmune, Experimental/drug therapy , Encephalomyelitis, Autoimmune, Experimental/pathology , Endothelin-1/metabolism , Female , Glial Fibrillary Acidic Protein/metabolism , Immunohistochemistry , Injections, Spinal , Male , Nerve Degeneration/drug therapy , Nerve Degeneration/pathology , Nerve Degeneration/physiopathology , Rats , Rats, Inbred Lew , Receptors, Endothelin/metabolism , Spinal Cord/pathology , Spinal Cord/physiopathology , Treatment Outcome
6.
J Clin Immunol ; 21(3): 155-70, 2001 May.
Article in English | MEDLINE | ID: mdl-11403222

ABSTRACT

Myelin/oligodendrocyte glycoprotein (MOG) is a surface-exposed antigen of myelin and an important target for autoimmune responses which mediate inflammatory demyelination in the central nervous system. Experimentally, MOG induces strong pathogenic T cell responses in many strains of laboratory animals. Immunological studies in humans also identify MOG as a surprisingly prevalent antigenic molecule among the myelin proteins. In addition, the encephalitogenic properties of MOG are linked to the induction of antibody responses which have been demonstrated to directly promote central nervous system demyelination, a hallmark neuropathological feature in disorders such as human multiple sclerosis. Factors responsible for autoimmunity to MOG likely include genetic influences as well as other mechanisms, which are the subject of intense investigation. This article reviews experimental data currently available on specificity and pathogenic roles of T cell and antibody responses against MOG, which have implications relevant to multiple sclerosis and related disorders.


Subject(s)
Demyelinating Autoimmune Diseases, CNS/immunology , Myelin-Associated Glycoprotein/immunology , Amino Acid Sequence , Animals , Antigens, Surface , Autoantibodies/biosynthesis , Autoantigens , B-Lymphocytes/immunology , Demyelinating Autoimmune Diseases, CNS/etiology , Disease Models, Animal , Encephalomyelitis, Autoimmune, Experimental/etiology , Encephalomyelitis, Autoimmune, Experimental/immunology , Humans , Mice , Molecular Sequence Data , Multiple Sclerosis/etiology , Multiple Sclerosis/immunology , Myelin Proteins , Myelin-Associated Glycoprotein/genetics , Myelin-Oligodendrocyte Glycoprotein , Primates , Rats , Sequence Homology, Amino Acid , T-Lymphocytes/immunology
7.
J Neuroimmunol ; 114(1-2): 40-7, 2001 Mar 01.
Article in English | MEDLINE | ID: mdl-11240014

ABSTRACT

Autoimmune inflammation in the central nervous system (CNS) is maintained by secretion of a large number of cytokines. To elucidate its molecular mechanisms, we examined the expression and localization of STAT1, STAT3, STAT4 and STAT6 molecules, which are the downstream molecules of the cytokine signal transduction pathway, in the CNS during acute experimental autoimmune encephalomyelitis (EAE) induced in Lewis rats. Western blot analysis demonstrated that STAT1 protein increased gradually till the recovery stage, whereas STAT4 protein showed abrupt increase at the early stage followed by gradual decrease. STAT3 and STAT6 showed stable expression throughout the course of the disease. The kinetics of the phosphorylated form of STAT1 and STAT4 roughly paralleled that of the total protein although the peak of STAT3 phosphorylation was recognized at the preclinical stage. Immunohistochemical examinations revealed that STAT3 and STAT4, but not STAT1 and STAT6, immunoreactivities were mainly expressed in astrocytes and microglia, respectively, and were closely associated with inflammatory lesions. Taken together, these findings suggest that STAT3 and STAT4 play an important role in the formation of, and recovery from, autoimmune inflammation in the CNS.


Subject(s)
DNA-Binding Proteins/metabolism , Encephalomyelitis, Autoimmune, Experimental/immunology , Spinal Cord/immunology , Trans-Activators/metabolism , Animals , Blotting, Western , DNA-Binding Proteins/analysis , Encephalomyelitis, Autoimmune, Experimental/metabolism , Immunohistochemistry , Kinetics , Phosphorylation , Rats , Rats, Inbred Lew , STAT1 Transcription Factor , STAT3 Transcription Factor , STAT4 Transcription Factor , STAT6 Transcription Factor , Spinal Cord/chemistry , Spinal Cord/metabolism , Trans-Activators/analysis , Tyrosine/metabolism
8.
Cancer Lett ; 161(1): 89-95, 2000 Dec 08.
Article in English | MEDLINE | ID: mdl-11078917

ABSTRACT

I-2(PP2A)/SET, an inhibitor of protein phosphatase 2A, is supposed to be one of the oncoproteins associated with human myeloid leukemia. The I-2(PP2A)/SET gene expression was observed ubiquitously among all the rat tissues examined, but low in liver. Of interest is that the expression in the rat primary hepatomas and hyperplastic nodules was significantly elevated. The experiments using regenerating livers after partial hepatectomy showed that the expression of I-2(PP2A)/SET mRNA was low at the quiescent hepatocytes, but up-regulated at 12-24 h after partial hepatectomy, which corresponds to the mid G1 to S transition in the cell cycle. These results suggested the importance of I-2(PP2A)/SET in the hepatocarcinogenesis and hepatic cell proliferation.


Subject(s)
Liver Neoplasms, Experimental/genetics , Liver Regeneration/genetics , Proteins/genetics , Amino Acid Sequence , Animals , Base Sequence , Chromosomal Proteins, Non-Histone , DNA, Complementary/genetics , DNA-Binding Proteins , Gene Expression Regulation, Neoplastic , Histone Chaperones , Liver/metabolism , Liver/physiology , Liver Neoplasms, Experimental/metabolism , Male , Mice , Molecular Sequence Data , Phosphoprotein Phosphatases/antagonists & inhibitors , Protein Biosynthesis , Protein Phosphatase 2 , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Rats, Wistar , Tissue Distribution , Transcription Factors , Up-Regulation
9.
J Neuroimmunol ; 108(1-2): 171-80, 2000 Aug 01.
Article in English | MEDLINE | ID: mdl-10900351

ABSTRACT

This study was undertaken to better understand the role of cytokines in the pathogenesis, especially in the mechanisms of relapse, of experimental autoimmune encephalomyelitis (EAE). For this purpose, we induced acute and chronic relapsing (CR) EAE in DA rats and determined several immunological parameters in rats at various stages of two types of EAE. Histopathological analysis revealed that there was no significant difference in the severity of inflammation in the spinal cord lesions between the two groups. However, demyelination was observed only in rats with CR EAE. Cytokine analysis by competitive PCR demonstrated that levels of TNF-alpha, IL-6 and IL-12 p40 mRNA in the spinal cord at the first attack of CR EAE were significantly higher than those at the peak stage of acute EAE. The mRNA expression of anti-inflammatory cytokines, IL-10 and TGF-beta1, was generally low in both acute EAE and the first attack of CR EAE and upregulated at later stages of CR EAE. These findings suggest that persistent high-level expression of pro-inflammatory cytokines is closely associated with demyelination and relapse of EAE. In contrast, anti-inflammatory cytokines play only a minor role in the relapse.


Subject(s)
Cytokines/genetics , Encephalomyelitis, Autoimmune, Experimental/genetics , Encephalomyelitis, Autoimmune, Experimental/pathology , Acute Disease , Amino Acid Sequence , Animals , Chronic Disease , Encephalomyelitis, Autoimmune, Experimental/immunology , Inflammation/genetics , Inflammation/immunology , Inflammation/pathology , Interferon-gamma/genetics , Interleukins/genetics , Molecular Sequence Data , Myelin Basic Protein/chemistry , Myelin Basic Protein/immunology , Peptide Fragments/chemistry , Peptide Fragments/immunology , RNA, Messenger/genetics , RNA, Messenger/metabolism , Rats , Rats, Inbred Strains , Recurrence , Reverse Transcriptase Polymerase Chain Reaction , Spinal Cord/metabolism , Spinal Cord/pathology , Transforming Growth Factor beta/genetics , Tumor Necrosis Factor-alpha/genetics
10.
Neurosci Lett ; 289(1): 41-4, 2000 Jul 28.
Article in English | MEDLINE | ID: mdl-10899404

ABSTRACT

The expression of pro-apoptotic molecules p53 and Bax in the spinal cord of rats with experimental autoimmune encephalomyelitis (EAE) was examined. Apoptosis was confirmed by the terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling (TUNEL) method. TUNEL (+) apoptotic cells were mainly either ED1 (+) macrophages or T-cells in the parenchyma of EAE. Western blot analysis showed that both p53 and Bax expression significantly (P<0. 01) increased in the spinal cords of EAE rats at the peak stage, and thereafter declined. An immunohistochemical study showed that inflammatory cells (notably T cells) in the parenchyma express p53 and Bax, while brain cells, including neurons and glia, were devoid of nuclear staining for these molecules. The nuclear expression of p53 largely matches apoptotic cells in the parenchyma of EAE. These findings suggest that the pro-apoptotic molecules p53 and Bax may play an important role in eliminating T cells in the parenchyma in EAE.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/metabolism , Proto-Oncogene Proteins c-bcl-2/biosynthesis , Proto-Oncogene Proteins/biosynthesis , Spinal Cord/metabolism , Tumor Suppressor Protein p53/biosynthesis , Animals , Apoptosis , Encephalomyelitis, Autoimmune, Experimental/pathology , Female , Immunohistochemistry , In Situ Nick-End Labeling , Male , Rats , Rats, Inbred Lew , bcl-2-Associated X Protein
11.
J Biol Chem ; 275(36): 28216-21, 2000 Sep 08.
Article in English | MEDLINE | ID: mdl-10859312

ABSTRACT

We engineered and expressed both a wild-type and mutant cytosolic isoform of PTPepsilon (PTPepsilonC) in murine M1 leukemic cells, which can be induced to growth arrest and monocytic differentiation by interleukin (IL)-6 and leukemia inhibitory factor (LIF). Forced expression of PTPepsilonC inhibited IL-6- and LIF-induced monocytic differentiation and apoptosis in M1 cells, whereas expression of PTPepsilonM, a transmembrane isoform of PTPepsilon, did not. PTPepsilonC expression resulted in lower levels of IL-6-induced tyrosine phosphorylation of Jak1, Tyk2, gp130, and Stat3 compared with parent cells. In M1 transfectants expressing an inactive mutant of PTPepsilonC, both tyrosine phosphorylation and apoptosis induced by IL-6 and LIF were potentiated rather than inhibited. These results suggest an important role for PTPepsilonC in negative regulation of IL-6- and LIF-induced Jak-STAT signaling.


Subject(s)
Cell Differentiation/physiology , DNA-Binding Proteins/metabolism , Growth Inhibitors/pharmacology , Interleukin-6/pharmacology , Lymphokines/pharmacology , Membrane Glycoproteins/metabolism , Protein Tyrosine Phosphatases/metabolism , Protein-Tyrosine Kinases/metabolism , Proteins/metabolism , Trans-Activators/metabolism , Animals , Apoptosis/drug effects , Apoptosis/physiology , Cell Differentiation/drug effects , Cell Survival/drug effects , Humans , Isoenzymes/metabolism , Janus Kinase 1 , Leukemia Inhibitory Factor , Leukemia, Myeloid, Acute , Lysosomal Membrane Proteins , Mice , Monocytes/cytology , Monocytes/physiology , Receptor-Like Protein Tyrosine Phosphatases, Class 4 , Recombinant Proteins/pharmacology , STAT3 Transcription Factor , Signal Transduction , TYK2 Kinase , Transfection , Tumor Cells, Cultured
12.
Acta Neurol Scand ; 101(3): 145-52, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10705935

ABSTRACT

OBJECTIVES: Phasic inhibition index (PII) is the rate of the simultaneous occurrence of phasic chin muscle activity (PCMA) and rapid eye movement bursts during rapid-eye-movement sleep (REMS). In naive patients with infantile spasms (IS), the PII value was found to reflect their prognosis. We studied the effects of adrenocorticotropic hormone (ACTH) on REMS components including PII in IS. METHODS: REMS parameters were examined in 18 IS patients before and after ACTH treatment. The effects of corticosteroids (CSs) were examined in 3 patients with congenital adrenal hyperplasia (CAH) and 3 with nephrotic syndrome (NS). RESULTS: ACTH decreased PII and PCMA in IS patients. In CAH patients, physiological doses of CSs corrected the increased intrinsic ACTH level and increased PII. In NS patients, therapeutic doses of CSs suppressed PCMA without affecting PII. CONCLUSION: ACTH suppressed PCMA through CSs, and reduced PII directly. ACTH was hypothesized to eliminate IS through these dual modes of action.


Subject(s)
Adrenal Cortex Hormones/pharmacology , Adrenal Cortex Hormones/therapeutic use , Adrenocorticotropic Hormone/pharmacology , Adrenocorticotropic Hormone/therapeutic use , Neural Inhibition/drug effects , Sleep, REM/drug effects , Spasms, Infantile/drug therapy , Adolescent , Adrenal Glands/pathology , Child , Chin/innervation , Electromyography/methods , Facial Muscles/innervation , Female , Follow-Up Studies , Humans , Hyperplasia/complications , Hyperplasia/congenital , Hyperplasia/pathology , Infant , Male , Nephrotic Syndrome/complications , Neural Conduction/drug effects , Polysomnography/methods , Spasms, Infantile/complications , Treatment Outcome
13.
J Neuroimmunol ; 104(1): 15-21, 2000 Apr 03.
Article in English | MEDLINE | ID: mdl-10683510

ABSTRACT

To elucidate the factor(s) accelerating the autoimmune disease processes, we induced two types of experimental autoimmune encephalomyelitis (EAE), severe and very mild, in F344 rats by immunization with myelin basic protein (MBP) plus pertussis toxin (PT) (PT+) or with MBP alone (PT-) and compared the differences between the two. Immunohistochemical examinations showed that although the nature of inflammation was essentially the same between the two groups, the proportion of Vbeta8.2(+) T cells in the CNS lesion of PT (+) rats was larger than that of PT (-) rats. Cytokine analysis by competitive PCR revealed that IL-10 mRNA in the lymphoid organ was significantly suppressed in the PT(+) group, whereas levels of IFN-gamma,TNF-alpha and TGF-beta mRNA were insignificantly different after PT administration. In addition, T cells taken from PT (+) rats proliferated well in response to MBP, while those from PT (-) rats showed a marginal response to the same antigen. However, this finding does not indicate the switching of non-encephalitogenic to encephalitogenic T cells upon PT administration because PT (-) rats contained encephalitogenic T cells and/or their precursor cells as revealed by adoptive transfer experiments. Taken together, these findings suggest that suppression of IL-10 by PT administration is the major factor contributing to the exacerbation of EAE in PT(+) rats.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/immunology , Pertussis Toxin , Virulence Factors, Bordetella/immunology , Animals , Cell Division , Central Nervous System/metabolism , Central Nervous System/pathology , Cytokines/metabolism , Encephalomyelitis, Autoimmune, Experimental/metabolism , Encephalomyelitis, Autoimmune, Experimental/pathology , Guinea Pigs , Immunization , Immunohistochemistry , Inflammation Mediators/metabolism , Myelin Basic Protein/immunology , Polymerase Chain Reaction , Rats , Rats, Inbred F344 , T-Lymphocytes/pathology
14.
J Neurosci Res ; 59(1): 145-52, 2000 Jan 01.
Article in English | MEDLINE | ID: mdl-10658195

ABSTRACT

Experimental autoimmune encephalomyelitis is a disease induced by neuroantigen-reactive T cells bearing particular types of T cell receptor (TCR). Although the nature of TCRs of encephalitogenic T cells has been partially delineated using encephalitogenic T cell clones established in vitro, the entire TCR repertoire formed in situ after immunization with neuroantigen remains unclear. In the present study, we immunized Lewis rats with myelin basic protein (MBP) and its fragment peptides and determined the TCR repertoire of spinal cord T cells formed after the immunization by CDR3 spectra-typing. It was revealed that the oligoclonal expansion of Vbeta2, Vbeta8.2, and Vbeta17 spectratypes was detectable after immunization with guinea pig MBP and its immunodominant epitope, the 68-88 sequence, whereas immunization with a peptide containing a minor epitope induced Vbeta10 expansion. Immunization with rat MBP induced much broader TCR Vbeta expansion (all of the above Vbetas plus Vbeta3). These findings suggest that TCRs activated by immunization with guinea pig MBP used as heteroclitic immunogen recognize autoantigen, rat MBP. Furthermore, the strategy used in this study gives insight into the pathogenesis of autoimmune disease and provides useful information for designing TCR-based immunotherapy.


Subject(s)
Complementarity Determining Regions , Encephalomyelitis, Autoimmune, Experimental/immunology , Epitopes/immunology , Myelin Basic Protein/immunology , Receptors, Antigen, T-Cell/immunology , Spinal Cord/immunology , T-Lymphocytes/immunology , Animals , Immunoglobulin Variable Region/analysis , Immunoglobulin Variable Region/genetics , Immunotherapy , Myelin Basic Protein/pharmacology , Rats , Rats, Inbred Strains , Receptors, Antigen, T-Cell, alpha-beta/immunology
15.
J Neuroimmunol ; 102(1): 67-72, 2000 Jan 03.
Article in English | MEDLINE | ID: mdl-10626668

ABSTRACT

To characterize experimental autoimmune neuritis (EAN)-inducing T cells in more detail, we performed CDR3 spectratyping analysis and found oligoclonal expansion of several Vbeta spectratypes in nerve-infiltrating T cells. Vbeta5 expansion was observed all the stages examined, whereas Vbeta8.2 and Vbeta17 expansion was mainly found at the peak and preclinical stages, respectively. Since Vbeta5 expansion persists throughout the course of the disease, Vbeta5+ T cells are judged to be the main effector cells. Vbeta8.2+ and Vbeta17+ T cells may also be pathogenic but are not the main effectors because expansion of these spectratypes was found at a limited period of time. Sequence analysis revealed that Vbeta5, Vbeta8.2 and Vbeta17 spectratype-derived TCR clones possess their own dominant sequences in the CDR3 region with no homology among the clones. These findings suggest that polyclonally activated T cells are involved in the formation of the nerve lesion. Furthermore, vaccination with Vbeta5 DNA, but not with Vbeta10 DNA, suppressed the development of EAN significantly. Collectively, these findings indicate that determination of autoimmune disease-associated TCR by CDR3 spectratyping provides useful information for designing TCR-based immunotherapy for the disease.


Subject(s)
Neuritis, Autoimmune, Experimental/immunology , Receptors, Antigen, T-Cell, alpha-beta/genetics , Receptors, Antigen, T-Cell, alpha-beta/immunology , Amino Acid Sequence/genetics , Animals , Base Sequence/genetics , Molecular Sequence Data , Myelin P2 Protein/immunology , Neuritis, Autoimmune, Experimental/prevention & control , Peptide Fragments/immunology , Rats , Rats, Inbred Lew , T-Lymphocytes/immunology , Vaccination , Vaccines, DNA/therapeutic use
16.
No To Hattatsu ; 32(6): 503-8, 2000 Nov.
Article in Japanese | MEDLINE | ID: mdl-11144164

ABSTRACT

Clinical symptoms and MR spectroscopic findings were studied on 4 cases of Pelizaeus-Merzbacher disease including 1 autopsy case. Common symptoms were severe mental retardation and spastic tetraplegia. These cases had nystagmus, and one had involuntary athetotic movement. Genetical diagnosis revealed in 2 cases, duplication of proteolipid protein (PLP) and deletion in 1, whereas one case had no abnormality of PLP gene. MRI indicated the reversal of signal intensities on T1- and T2-weighed images, a characteristic finding of PMD MR spectroscopy demonstrated a pattern of NAA in 3 cases. This was specific to PMD because other white matter diseases show a decrease in NAA. In conclusion, MRS was useful to differentiate PMD from other white matter diseases.


Subject(s)
Aspartic Acid/analogs & derivatives , Magnetic Resonance Spectroscopy , Pelizaeus-Merzbacher Disease/diagnosis , Adult , Aspartic Acid/metabolism , Brain/metabolism , Brain/pathology , Diagnosis, Differential , Female , Gene Deletion , Gene Duplication , Humans , Magnetic Resonance Imaging , Male , Myelin Proteolipid Protein/genetics , Pelizaeus-Merzbacher Disease/physiopathology
17.
Neuropathology ; 20(4): 297-303, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11211054

ABSTRACT

Whether the cerebral or subcortical lesions are involved in the pathogenesis in infantile spasms (IS) remains to be determined. To investigate the functional lesions of the subcortical structures in IS, the brainstem expression of neurotransmitters, neuropeptides and calcium-binding proteins in IS autopsy cases of lissencephaly and of perinatal hypoxic ischemic encephalopathy (HIE/IS) was investigated. The IS patients consisted of four subjects each of lissencephaly and HIE. They suffered from both West and Lennox-Gastaut syndromes. The healthy and disease controls were composed of four subjects without neuromuscular disorders and six cases of HIE (HIE/C), neither of whom had the epileptic syndrome. In these subjects the expressions of tryptophan hydroxylase (TrH), tyrosine hydroxylase (TH), parvalbumin (PV), methionine-enkephalin (ME) and substance P (SP) were immunohistochemically determined in serial sections of the midbrain, pons and medulla oblongata. The immunoreactivity of neurons and neuronal processes for TH was altered in the mesencephalic periaqueductal gray matter, locus ceruleus, and dorsal vagal nucleus in the patients. The HIE/IS cases showed reduced TrH-immunoreactivity in the medullary raphe nuclei. The brainstem auditory tract was poorly discernible on anti-PV immunostaining in the IS patients. The immunoreactivity for ME in the spinal trigeminal nucleus was severely affected in the IS patients, while that for SP was comparatively well preserved. It is suggested that the presence of common brainstem lesions in IS is irrespective of etiologies. It is intriguing that some of the changes seemed to be interrelated with the neurophysiological abnormalities being reported in IS patients.


Subject(s)
Brain Stem/pathology , Calcium-Binding Proteins/analysis , Neuropeptides/analysis , Neurotransmitter Agents/analysis , Spasms, Infantile/pathology , Spasms, Infantile/physiopathology , Adolescent , Adult , Brain Stem/physiopathology , Child , Child, Preschool , Enkephalin, Methionine/analysis , Humans , Immunohistochemistry , Infant , Neurons/pathology , Parvalbumins/analysis , Substance P/analysis , Tryptophan Hydroxylase/analysis , Tyrosine 3-Monooxygenase/analysis
18.
J Vet Sci ; 1(1): 11-7, 2000 Jun.
Article in English | MEDLINE | ID: mdl-14612615

ABSTRACT

To elucidate the role of nitric oxide synthase (NOS) in the pathogenesis of experimental autoimmune encephalomyelitis (EAE), we analyzed the expression of constitutive neuronal NOS (nNOS), endothelial NOS (eNOS), and inducible NOS (iNOS) in the spinal cords of rats with EAE. We further examined the structural interaction between apoptotic cells and spinal cord cells including neurons and astrocytes, which are potent cell types of nitric oxide (NO) production in the brain. Western blot analysis showed that three forms of NOS significantly increased in the spinal cords of rats at the peak stage of EAE, while small amounts of these enzymes were identified in the spinal cords of rats without EAE. Immunohistochemical study showed that the expression of either nNOS or eNOS increased in the brain cells including neurons and astrocytes during the peak and recovery stages of EAE, while the expression of iNOS was found mainly in the inflammatory macrophages in the perivascular EAE lesions. Double labeling showed that apoptotic cells had intimate contacts with either neurons or astrocytes, which are major cell types to express nNOS and eNOS constitutively. Our results suggest that the three NOS may play an important role in the recovery of EAE.


Subject(s)
Encephalomyelitis, Autoimmune, Experimental/enzymology , Nitric Oxide Synthase/metabolism , Spinal Cord/enzymology , Animals , Apoptosis , Endothelium, Vascular/enzymology , Immunohistochemistry , In Situ Nick-End Labeling , Male , Nitric Oxide Synthase Type I , Nitric Oxide Synthase Type II , Nitric Oxide Synthase Type III , Rats , Rats, Inbred Lew , Spinal Cord/pathology
19.
Eur J Neurosci ; 11(11): 4139-44, 1999 Nov.
Article in English | MEDLINE | ID: mdl-10583502

ABSTRACT

Recent studies have shown that hepatocyte growth factor (HGF) promotes the survival of embryonic motor neurons. However, it remains unclear whether HGF has trophic effects on mature motor neurons. In the present study, we examined the effects of HGF on adult motoneurons using the hypoglossal nerve transection model. In adult rats, neurons in the hypoglossal nucleus show a dramatic loss of choline acetyltransferase (ChAT) protein and mRNA after the axotomy. This reduction of ChAT was markedly prevented when HGF was administered continuously at the cut end of the nerve using an osmotic pump. The HGF receptor, c-met, protein and mRNA, which were faintly expressed in hypoglossal neurons under normal conditions, gradually increased and reached maximal levels 2 weeks after the axotomy. Administration of HGF reduced this c-met upregulation almost to normal levels. We also quantified HGF mRNA in the tongue and hypoglossal nucleus. The tongue contained abundant HGF mRNA, whereas the nucleus contained only low levels. Interestingly, the HGF mRNA level in the nucleus did not increase after the axotomy. These findings suggest that HGF is principally produced in the tongue and contributes to maintain ChAT expression in the nucleus. HGF produced in the hypoglossal nucleus alone after disconnection from the tongue may not be sufficient for the maintenance of the motor neuron function. Thus, exogenously applied HGF was effective to prevent the downregulation of ChAT activities. These findings provide a strong rationale for the potential clinical use of HGF for the treatment of motor neuron degenerative disease.


Subject(s)
Hepatocyte Growth Factor/pharmacology , Hypoglossal Nerve/physiology , Motor Neurons/physiology , Nerve Growth Factors/pharmacology , Animals , Axotomy , Choline O-Acetyltransferase/genetics , Choline O-Acetyltransferase/metabolism , Gene Expression Regulation/drug effects , Hepatocyte Growth Factor/administration & dosage , Hepatocyte Growth Factor/genetics , Infusions, Parenteral , Male , Medulla Oblongata/physiology , Models, Neurological , Motor Neurons/drug effects , Proto-Oncogene Proteins c-met/genetics , RNA, Messenger/genetics , Rats , Rats, Inbred F344 , Tongue/physiology , Transcription, Genetic , Up-Regulation/drug effects
20.
J Neuroimmunol ; 96(1): 66-72, 1999 Apr 01.
Article in English | MEDLINE | ID: mdl-10227425

ABSTRACT

To characterize the nature of the alpha chain of TCR associated with the development of experimental autoimmune encephalomyelitis (EAE), spinal cord T cells isolated from individual rats with preclinical and clinical EAE were investigated by CDR3 spectratyping and subsequently, the amino acid sequences of the CDR3 region of oligoclonally expanded TCR determined. In contrast to the beta chain repertoire in which Vbeta8.2 with the shortest CDR3 is the predominant population throughout the course, multiple oligoclonal expansion was observed at all time points examined. Characteristically, Valpha1 and Valpha2 expansion was observed at preclinical and early stages, whereas that of Valpha8, Valpha13 and Valpha23 was detected at early and peak stages. Sequence analysis of the CDR3 region revealed that the former group possessed an asparagine repeat in the middle portion, whereas the latter group had the KLTF motif in the C terminal region of CDR3. These findings suggest that Valpha usage by EAE-associated T cells is stage-dependent and that EAE is induced by polyclonally activated T cells which switch TCR alpha chain, but not beta chain, phenotype as the disease progresses.


Subject(s)
CD3 Complex/analysis , Encephalomyelitis, Autoimmune, Experimental/immunology , Spinal Cord/immunology , T-Lymphocytes/chemistry , Amino Acid Sequence , Animals , Autoimmune Diseases/immunology , CD3 Complex/genetics , DNA Primers , DNA, Complementary , Immunoglobulin Variable Region/immunology , Immunophenotyping , Molecular Sequence Data , Rats , Rats, Inbred Lew , Spinal Cord/cytology , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...